DOI:

Transcatheter mitral valve-in-valve/valve-in-ring implantations for degenerative post-surgical valves: results from the global valve-in-valve registry

Dvir D.1,18, Webb J.2, Schaefer U.3, Treede H.4, Bleiziffer S.5, Latib A.6, Fiorina C.7, Rodés-Cabau J.8, Wilbring M.9, Cerillo A.10, Descoutures F.11, Guetta V.12, De Weger A.13, Bekeredjian R.14, Segev A.12, Tchetche D.15, Teles R.16, Ye J.2, Eltchaninoff H.17, Kornowski R.18

Single and multicentre TAVI registries

Transcatheter mitral valve-in-valve/valve-in-ring implantations for degenerative post-surgical valves: results from the global valve-in-valve registry

Aims: Transcatheter mitral valve-in-valve / valve-in-ring implantation is an emerging therapeutic alternative for patients with failed mitral valves after surgical intervention and may obviate the need for a redo operation. We aimed to evaluate the clinical results of this technique using a large worldwide registry.

Methods and results: The registry included 70 patients with degenerated mitral valves after surgical intervention (11.4% ring only, median of nine years post procedure) from 17 centres. Mean age 74.0±11.3 years; 70% female (STS score 16.2±10.4%). The mode of failure was regurgitation (n=36, 51.4%), stenosis (n=13, 18.6%), and combined stenosis and regurgitation (n=21, 30%). Transcatheter Edwards SAPIEN (Edwards Lifesciences, Irvine, CA, USA) implantation was performed in all cases (23 mm in 22.9%, 26 mm in 58.6%, and 29 mm in 18.6%). Procedural access was transapical in 60 cases (85.7%); transseptal in seven (10%), and through the left atrium via right mini-thoracotomy in three (4.3%). Combined procedures included three aortic valve-in-valves, transapical aortic valve replacement, tricuspid valve-in-ring implantation, and transapical paravalvular leak closure. Device malposition appeared in 4.3% of cases and post-implantation valvuloplasty was utilised in 12.1%. Post procedure, mitral valve area was 2.1±0.6 cm2, valve maximum / mean gradients were 13.6±6.4 mmHg / 6.4±2.7, respectively, and significant mitral regurgitation (≥+2) was observed in 5.7% of patients. Median length of hospital stay was seven days. At 30-day follow-up, all-cause mortality was 10.3% and 82.3% were at New York Heart Association functional Class I/II.

Conclusions: Mitral valve-in-valve/ valve-in-ring implantations, performed in very high-risk patients, were clinically effective in most patients with degenerative mitral valves after surgery. The safety and efficacy of this approach should be further examined.

Volume 8 Supplement Q
Sep 30, 2012
Volume 8 Supplement Q
View full issue


Key metrics

Suggested by Cory

Image – Interventional flashlight

10.4244/EIJ-D-21-00871 Oct 21, 2022
Redo transcatheter mitral valve replacement in mitral annular calcification
Jdaidani J et al
free

MITRAL VALVE INTERVENTIONS

10.4244/EIJV12SYA25 Sep 18, 2016
Mitral valve-in-valve and valve-in-ring: technical aspects and procedural outcomes
Dvir D and Webb JG
free

10.4244/EIJV16I17A252 Apr 20, 2021
How to eliminate mitral regurgitation definitively: the eternal dilemma?
Modine T and Ben Ali W
free

10.4244/EIJV10I2A42 Jun 20, 2014
Balloon-expandable valves for degenerated mitral xenografts or failing surgical rings
Schäfer U et al
free

Editorial

10.4244/EIJ-E-24-00002 Mar 4, 2024
Catheter-based versus surgical mitral valve intervention: choosing between the red pill and the blue pill
Bagur R and McInerney A
free

Clinical research

10.4244/EIJ-D-22-01037 Aug 21, 2023
Clinical outcomes of transcatheter mitral valve replacement: two-year results of the CHOICE-MI Registry
Ludwig S et al
free
Trending articles
151.43

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
55.9

Clinical research

10.4244/EIJ-D-22-00621 Feb 20, 2023
Long-term changes in coronary physiology after aortic valve replacement
Sabbah M et al
free
54.9

Expert review

10.4244/EIJ-D-21-01010 Jun 24, 2022
Device-related thrombus following left atrial appendage occlusion
Simard T et al
free
43.75

Clinical Research

10.4244/EIJ-D-21-01091 Aug 5, 2022
Lifetime management of patients with symptomatic severe aortic stenosis: a computed tomography simulation study
Medranda G et al
free
39.95

Clinical research

10.4244/EIJ-D-22-00558 Feb 6, 2023
Permanent pacemaker implantation and left bundle branch block with self-expanding valves – a SCOPE 2 subanalysis
Pellegrini C et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved